Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.035,69
-1,57%
NASDAQ Composite
15.657,82
-2,04%
Bitcoin
56.904,55
-6,10%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Mind Medicine MindMed Inc (MNMD) Mind Medicine MindMed Inc (MNMD) Notizie

Mind Medicine MindMed Inc

MNMD
9,52
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 11:18:27
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/4/202413:00BWMindMed to Present at Upcoming May Medical Conferences
02/4/202413:00BWMindMed to Present at Upcoming April Medical Conferences
01/4/202423:00BWMindMed Announces Voluntary Delisting from Cboe Canada
11/3/202413:32EDGAR2Form 8-K - Current report
11/3/202412:00BWMindMed to Participate in the Leerink Partners 2024 Global..
07/3/202414:19EDGAR2Form 8-K - Current report
07/3/202413:13BWMind Medicine (MindMed) Inc. Announces Pricing of..
07/3/202413:09EDGAR2Form S-3MEF - Registration adding securities to prior Form..
07/3/202412:56EDGAR2Form 8-K - Current report
07/3/202412:00BWMindMed Receives FDA Breakthrough Therapy Designation and..
01/3/202419:56EDGAR2Form 144 - Report of proposed sale of securities
01/3/202415:00BWMindMed to Host Conference Call and Webcast to Discuss Data..
29/2/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202413:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202413:15EDGAR2Form 8-K - Current report
28/2/202413:05BWMindMed Reports 2023 Financial Results and Business Updates
22/2/202413:00BWMindMed to Host Conference Call and Webcast to Discuss 2023..
07/2/202413:00BWMindMed to Participate in the 34th Annual Oppenheimer..
08/1/202414:00EDGAR2Form 8-K - Current report
08/1/202413:45BWMindMed Announces Business Update and Anticipated Milestones..
26/12/202322:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202322:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202322:24EDGAR2Form 144 - Report of proposed sale of securities
14/12/202313:57EDGAR2Form 8-K - Current report
14/12/202313:30BWMindMed Announces Positive Topline Results from Phase 2b..
02/11/202321:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:15EDGAR2Form 8-K - Current report
02/11/202321:01BWMindMed Reports Third Quarter 2023 Financial Results and..
26/10/202313:30BWMindMed to Host Conference Call and Webcast to Discuss Third..
24/10/202313:30BWMindMed Completes Enrollment of Phase 2a Trial of MM-120 in..
03/10/202313:30BWMindMed to Present Data on the Preclinical Activity of..
26/9/202303:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202303:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202303:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202303:02EDGAR2Form 144 - Report of proposed sale of securities
26/9/202303:01EDGAR2Form 144 - Report of proposed sale of securities
26/9/202303:01EDGAR2Form 144 - Report of proposed sale of securities
15/9/202323:27EDGAR2Form 8-K/A - Current report: [Amend]
15/9/202323:23EDGAR2Form 8-K/A - Current report: [Amend]
14/9/202313:30BWMindMed to Participate in the TD Cowen 3rd Annual Novel..
12/9/202313:30BWMindMed Completes Enrollment of Phase 2b Trial of MM-120 in..
29/8/202302:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202316:35EDGAR2Form 144 - Report of proposed sale of securities
28/8/202315:16EDGAR2Form 144 - Report of proposed sale of securities
28/8/202313:30BWMindMed to Participate at September Investor Conferences
14/8/202314:31EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 9,52

La tua Cronologia

NASDAQ
MNMD
Mind Medicine MindMed
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network